The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index; 4 of the 6 sources its claims cite were checked for support.
Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice
Open accessAbstract
An ageing world population has fuelled interest in regenerative remedies that may stem declining organ function and maintain fitness. Unanswered is whether elimination of intrinsic instigators driving age-associated degeneration can reverse, as opposed to simply arrest, various afflictions of the aged. Such instigators include progressively damaged genomes. Telomerase-deficient mice have served as a model system to study the adverse cellular and organismal consequences of wide-spread endogenous DNA damage signalling activation in vivo. Telomere loss and uncapping provokes progressive tissue atrophy, stem cell depletion, organ system failure and impaired tissue injury responses. Here, we sought to determine whether entrenched multi-system degeneration in adult mice with severe telomere dysfunction can be halted or possibly reversed by reactivation of endogenous telomerase activity. To this end, we engineered a knock-in allele encoding a 4-hydroxytamoxifen (4-OHT)-inducible telomerase reverse transcriptase-oestrogen receptor (TERT-ER) under transcriptional control of the endogenous TERT promoter. Homozygous TERT-ER mice have short dysfunctional telomeres and sustain increased DNA damage signalling and classical degenerative phenotypes upon successive generational matings and advancing age. Telomerase reactivation in such late generation TERT-ER mice extends telomeres, reduces DNA damage signalling and associated cellular checkpoint responses, allows resumption of proliferation in quiescent cultures, and eliminates degenerative phenotypes across multiple organs including testes, spleens and intestines. Notably, somatic telomerase reactivation reversed neurodegeneration with restoration of proliferating Sox2(+) neural progenitors, Dcx(+) newborn neurons, and Olig2(+) oligodendrocyte populations. Consistent with the integral role of subventricular zone neural progenitors in generation and maintenance of olfactory bulb interneurons, this wave of telomerase-dependent neurogenesis resulted in alleviation of hyposmia and recovery of innate olfactory avoidance responses. Accumulating evidence implicating telomere damage as a driver of age-associated organ decline and disease risk and the marked reversal of systemic degenerative phenotypes in adult mice observed here support the development of regenerative strategies designed to restore telomere integrity.
Overview
CoChat Summary
## TL;DR
In aged telomerase-deficient TERT-ER mice, a 4-week course of 4-OHT-induced telomerase reactivation reversed multiple degenerative phenotypes rather than merely halting them. The treatment restored telomere signal and reduced DNA damage responses, with functional recovery in testes, spleen, intestine, brain myelination, and innate olfactory behavior.
## Key findings
- G4 TERT-ER mice phenocopied late-generation telomerase-deficient mice and had reduced survival: median survival was 43.5 vs. 86.8 weeks for telomere-intact mice.
- After 4 weeks of 4-OHT, telomerase reactivation increased telomere-FISH signal, reduced p53 activation, reduced p21 expression, and decreased 53BP1 foci in splenocytes and intestinal crypt cells.
- Telomerase reactivation reversed tissue degeneration, including restoration of normal testes and spleen size, reduced apoptosis in testes germ cells and intestinal crypt cells, and increased fecundity.
- In the brain, treatment restored Sox2+ neural progenitors, DCX+ newborn neurons, and Olig2+ oligodendrocytes; brain weight improved from 77.3 ± 3.3% to 89.7 ± 4.0% of G0 levels, and the myelin g-ratio shifted from 0.7756 ± 0.0054 in G4 mice toward 0.7058 ± 0.0006 after treatment.
- Innate olfactory avoidance recovered: untreated G4 mice failed to avoid lower 2-MB concentrations, but after 4-OHT they showed avoidance at all tested concentrations (1.87 × 10^-4 M to 1.87 × 10^-6 M).
## Methods
- The authors generated a knock-in TERT-ER mouse with a 4-hydroxytamoxifen (4-OHT)-inducible telomerase reverse transcriptase-estrogen receptor fusion under the endogenous TERT promoter; studies used adult male mice, typically 30–35 weeks old, across successive generations (G0 to G4).
- They assessed telomerase activity, telomere status, DNA damage markers, histology, neurosphere self-renewal and differentiation, myelination, and olfactory behavior using TRAP assays, IHC/FISH, cell culture, electron microscopy, and behavioral testing.
- Statistical analysis used one-way ANOVA with Bonferroni post test and Mantel-Cox tests for survival curves.
## Limitations
- The paper states that carcinogenesis was not observed after the brief telomerase reactivation course, but also notes this was “data not shown” and that longer or later-life reactivation may provoke carcinogenesis.
- The study was performed on adult males only, so the text makes evident a sex limitation.
- The olfactory test sample sizes were small in the methods (n=4 per experimental condition), which is evident from the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
3 Valid · 0 Not valid · 1 Not checked · 19 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Thus, G4 TERT-ER mice phenocopy late generation mTert -/- and mTerc -/- animals 13 , 14 , indicating that TERT-ER is inactive in the absence of 4-OHT.”
What the sources say
- Partly supportedcites [13] Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25–34 (1997) sourceExperimental — accuracy not yet measured
The Abstract reports progressive telomere loss and frequent chromosomal rearrangements in later generations of mTR−/− mice, supporting the comparison to mTerc−/− animals. It does not study mTert−/− or TERT-ER mice, so it cannot establish that G4 TERT-ER mice phenocopy both groups. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [14] Wong, K. K. et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421, 643–648 (2003) source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Notably, somatic telomerase reactivation reversed neurodegeneration with restoration of proliferating Sox2+ neural progenitors, DCX+ newborn neurons, and Olig2+ oligodendrocyte populations.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Consistent with the integral role of SVZ neural progenitors in generation and maintenance of olfactory bulb interneurons 2 , this wave of telomerase-dependent neurogenesis resulted in alleviation of hyposmia and recovery of innate olfactory avoidance responses.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Figure 2. Telomerase activation in adult TERT-ER mice”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Notably, somatic telomerase reactivation reversed neurodegeneration with restoration of proliferating Sox2+ neural progenitors, DCX+ newborn neurons, and Olig2+ oligodendrocyte populations.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
13 more claims
Create a free account to see all 23 claims and every source verdict.
- It may state two separate claims as one. 2
- Probably not a substantial claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mice, segmental premature ageing only manifest in telomerase mutants after several generations, likely because their particularly long telomeric repeats take several generations to become critically shortened and thus dysfunctional16.”
From The central role of DNA damage in the ageing process (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“neural stem cells from mTERC-reactivated animals showed enhanced multipotency, suggesting recovered neurogenic function.”
From Stem cell aging: mechanisms, regulators and therapeutic opportunities (2014) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mice with telomerase deficiency serve as a robust model for studying anti-aging effects as they closely resemble natural aging and reflect various pathophysiological states during the aging process, making them more representative compared to other aging mouse models induced by different methods (Jaskelioff et al., 2011).”
From Exploring the anti-aging effects of fisetin in telomerase-deficient progeria mouse model (2023) · cites this paper as Jaskelioff et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, in post-mitotic neurons, restoration of physiological TERT levels improve capacity for neural stem cell regeneration, enhance synaptic plasticity and preserve cognitive function in two models of Alzheimer’s Disease.15,16”
From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, in genetically engineered mice, TERT reactivation studies revealed the dual role of TERT in the reversal of aging via telomere synthesis in proliferative tissues as well as via gene expression modulation in post-mitotic tissues in a telomere-independent manner.”
From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [15]
Experimental — accuracy not yet measured
13 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Innate olfactory avoidance test
“For innate avoidance tests, circular filter paper (2.5cm diameter) was scented with 40 μl of either water or progressively higher concentrations of 2-MB (1.74 × 10 -6 M through 1.74 × 10 -4 M)”
§ Abstract
“Whereas G0 TERT-ER mice demonstrated avoidance responses at all 2-MB concentrations tested (1.87×10 -4 M through 1.87×10 -6 M), G4 mice showed attraction/neutral behaviors at concentrations lower than 1.87×10 -4 M (Figure 5e,f).”
Citations
Cites
Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 15,112
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Hoeijmakers, J. H. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804615 · Cited by 2,239
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationAssociation between telomere length in blood and mortality in people aged 60 years or older
Cawthon, R. M., Smith, K. R., O'Brien, E., Sivatchenko, A., & Kerber, R. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12384-7 · Cited by 1,761
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Self-citationLinking functional decline of telomeres, mitochondria and stem cells during ageing
Sahin, E., & DePinho, R. A. (2010) · Nature · doi:10.1038/nature08982 · Cited by 759
Self-citationHow stem cells age and why this makes us grow old
Sharpless, N. E., & DePinho, R. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2241 · Cited by 743
Self-citationInnate versus learned odour processing in the mouse olfactory bulb
Kobayakawa, K., Kobayakawa, R., Matsumoto, H., Oka, Y., Imai, T., Ikawa, M., Okabe, M., Ikeda, T., Itohara, S., Kikusui, T., et al. (2007) · Nature · doi:10.1038/nature06281 · Cited by 671
Chan, S. R. W. L., & Blackburn, E. H. (2004) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1370 · Cited by 595
Cited by
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
“In particular, the premature aging of telomerase-deficient mice can be reverted when telomerase is genetically reactivated in these agedmice (Jaskelioff et al., 2011).”
BackgroundHallmarks of aging: An expanding universe
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023) · Cell · doi:10.1016/j.cell.2022.11.001 · Cited by 6,549
Ageing as a Risk Factor for Disease
Niccoli, T., & Partridge, L. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.024 · Cited by 1,831
“Telomerase expression is high in neuronal stem cells and is important for brain development [92]; it decreases in differentiated neurons, but can be reactivated in response to stress, where it may play a protective role, because inhibiting telomerase increases neurons’ susceptibility to apoptosis [93].”
BackgroundHallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States
Mattson, M. P., & Arumugam, T. V. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.011 · Cited by 1,242
Senescence and aging: Causes, consequences, and therapeutic avenues
McHugh, D., & Gil, J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708092 · Cited by 1,233
“Cells isolated from these mice proliferate normally in vitro, and deterioration in multiple tissues is reduced (Jaskelioff et al., 2011).”
BackgroundForging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104
Wang (2012) · doi:10.1161/circresaha.111.261388 · Cited by 957
The central role of DNA damage in the ageing process
Schumacher, B., Pothof, J., Vijg, J., & Hoeijmakers, J. H. J. (2021) · Nature · doi:10.1038/s41586-021-03307-7 · Cited by 907
Identification of seven loci affecting mean telomere length and their association with disease
CARDIoGRAM consortium, Codd, V., Nelson, C. P., Albrecht, E., Mangino, M., Deelen, J., Buxton, J. L., Hottenga, J. J., Fischer, K., Esko, T., et al. (2013) · Nature Genetics · doi:10.1038/ng.2528 · Cited by 933
Stem cell aging: mechanisms, regulators and therapeutic opportunities
Oh, J., Lee, Y. D., & Wagers, A. J. (2014) · Nature Medicine · doi:10.1038/nm.3651 · Cited by 796
Telomere length in early life predicts lifespan
Heidinger, B. J., Blount, J. D., Boner, W., Griffiths, K., Metcalfe, N. B., & Monaghan, P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113306109 · Cited by 713
“Progressive telomere shortening has been linked to both normal aging and to various degenerative diseases in a wide range of studies mainly in humans and mice (2), and telomere lengthening has been shown to have a restorative effect (11).”
BackgroundOlshansky, S. J., Antonucci, T., Berkman, L., Binstock, R. H., Boersch-Supan, A., Cacioppo, J. T., Carnes, B. A., Carstensen, L. L., Fried, L. P., Goldman, D. P., et al. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.0746 · Cited by 693
Rejuvenation of Regeneration in the Aging Central Nervous System
Ruckh, J. M., Zhao, J.-W., Shadrach, J. L., van Wijngaarden, P., Rao, T. N., Wagers, A. J., & Franklin, R. J. M. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.11.019 · Cited by 649
“Recent data suggest that age-associated defects in neural stem cells can be reversed by reactivation of telomerase (Jaskelioff et al., 2011), suggesting that aged OPCs might, in principle, remain competent for efficient remyelination.”
BackgroundThe effects of aging in the hippocampus and cognitive decline
Bettio, L. E. B., Rajendran, L., & Gil-Mohapel, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.030 · Cited by 649
“…of telomeres can be reversed in several tissues by restoring telomere integrity through reactivation of telomerases (reverse transcriptase enzymes that add telomere repeats de novo), reinforced the hypothesis that these structures play an important role in stem cell aging (Jaskelioff et al., 2011).”
Telomeres: history, health, and hallmarks of aging
Chakravarti, D., LaBella, K. A., & DePinho, R. A. (2021) · Cell · doi:10.1016/j.cell.2020.12.028 · Cited by 637
“Advancing knowledge of the molecular networks regulated by telomerase and rejuvenation of prematurely aged mice with telomerase activation (Jaskelioff et al., 2011) has fueled interest in development of agents that activate TERT expression for antiaging therapy.”
BackgroundInfluentialSelf-citationBernardes de Jesus, B., Vera, E., Schneeberger, K., Tejera, A. M., Ayuso, E., Bosch, F., & Blasco, M. A. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200245 · Cited by 548
“…re-activation of telomerase in a model of premature aging caused by accelerated telomere shortening owing to telomerase deficiency (TERT-deficient mice; Jaskelioff et al, 2011) was enough to revert some age-associated phenotypes, suggesting that accelerated aging produced by telomere shortening can…”
InfluentialTelomere Length in Epidemiology: A Biomarker of Aging, Age-Related Disease, Both, or Neither?
Sanders, J. L., & Newman, A. B. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxs008 · Cited by 537
“The large effect that telomere length might have on longevity was demonstrated recently when researchers knocked in telomerase activity to aged telomerase-deficient mice with short telomeres (13).”
BackgroundAging, Rejuvenation, and Epigenetic Reprogramming: Resetting the Aging Clock
Rando, T. A., & Chang, H. Y. (2012) · Cell · doi:10.1016/j.cell.2012.01.003 · Cited by 520
“Intriguingly, the reactivation of telomerase in adult tissue stem cells with experimentally shortened telomeres is sufficient to reverse degenerative pathologies—some typical of aged tissues—in multiple organs (Jaskelioff et al., 2011).”
Asghar, M., Hasselquist, D., Hansson, B., Zehtindjiev, P., Westerdahl, H., & Bensch, S. (2015) · Science · doi:10.1126/science.1261121 · Cited by 514
Neurogenesis in the embryonic and adult brain: same regulators, different roles
Urbán, N., & Guillemot, F. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00396 · Cited by 493
“This decrease has been attributed both to a reduction of the NSC pool and to an increased state of quiescence of the remaining stem cells (Lugert et al., 2010; Encinas et al., 2011; Jaskelioff et al., 2011; Seib et al., 2013).”
BackgroundRenal Aging: Causes and Consequences
O’Sullivan, E. D., Hughes, J., & Ferenbach, D. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121308 · Cited by 484
A synopsis on aging—Theories, mechanisms and future prospects
da Costa, J. P., Vitorino, R., Silva, G. M., Vogel, C., Duarte, A. C., & Rocha-Santos, T. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.06.005 · Cited by 456
DNA Damage, DNA Repair, Aging, and Neurodegeneration
Maynard, S., Fang, E. F., Scheibye-Knudsen, M., Croteau, D. L., & Bohr, V. A. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025130 · Cited by 438
“Telomerase reactivation (and telomere elongation) reverses age-related pathology in mice (Jaskelioff et al. 2011); however, early death often occurs because of tumor formation (Gonzalez-Suarez et al.”
BackgroundTelomeres and cell senescence—size matters not
Victorelli, S., & Passos, J. F. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.027 · Cited by 413
“Moreover, it has been shown that reintroduction of telomerase activity in telomerase-deficient mice is able to revert the premature ageing phenotype observed in tissues such as the spleen, intestine and testes (Jaskelioff et al., 2011).”
BackgroundMechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395
“Transgenic mouse models without or with inducible telomerase [300,301] allowed establishing a link between short telomeres and the onset of aging phenotypes [300,302,303], progeroid syndromes [304], and chronic inflammatory and degenerative conditions [305,306].”
BackgroundStress exposure in intrauterine life is associated with shorter telomere length in young adulthood
Entringer, S., Epel, E. S., Kumsta, R., Lin, J., Hellhammer, D. H., Blackburn, E. H., Wüst, S., & Wadhwa, P. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107759108 · Cited by 392
“A recent study in mice suggests that telomerase plays a causal role in aging and regeneration of cells, tissues, and physiological function (16).”
BackgroundAgeing and the telomere connection: An intimate relationship with inflammation
Zhang, J., Rane, G., Dai, X., Shanmugam, M. K., Arfuso, F., Samy, R. P., Lai, M. K. P., Kappei, D., Kumar, A. P., & Sethi, G. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2015.11.006 · Cited by 386
Axis of ageing: telomeres, p53 and mitochondria
Sahin, E., & DePinho, R. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3352 · Cited by 345
Self-citationFinding the end: recruitment of telomerase to telomeres
Nandakumar, J., & Cech, T. R. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3505 · Cited by 378
Polygenic basis and biomedical consequences of telomere length variation
Codd, V., Wang, Q., Allara, E., Musicha, C., Kaptoge, S., Stoma, S., Jiang, T., Hamby, S. E., Braund, P. S., Bountziouka, V., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00944-6 · Cited by 379
de Jesus, B. B., Schneeberger, K., Vera, E., Tejera, A., Harley, C. B., & Blasco, M. A. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00700.x · Cited by 348
Anti-Aging Implications of Astragalus Membranaceus (Huangqi): A Well-Known Chinese Tonic
Liu, P., Zhao, H., & Luo, Y. (2017) · Aging and disease · doi:10.14336/ad.2017.0816 · Cited by 347
“number of studies have shown that activating telomerase can maintain telomere length, delay aging, and reverse age tissue degeneration [210,211].”
BackgroundO'Donovan, A., Pantell, M. S., Puterman, E., Dhabhar, F. S., Blackburn, E. H., Yaffe, K., Cawthon, R. M., Opresko, P. L., Hsueh, W.-C., Satterfield, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019687 · Cited by 341
“Importantly, telomere shortening is not just an index, but also a potential mechanism underlying some aspects of biological aging because short telomere length can lead to cessation of mitosis with consequent loss of ability for cell replenishment and, in some cellular settings, genomic instability, end-to-end chromos…”
BackgroundStress, cell senescence and organismal ageing
de Magalhães, J. P., & Passos, J. F. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.07.001 · Cited by 316
“Reintroduction of telomerase in telomerasedeficient mice is able to revert the premature ageing phenotype observed in various tissues (Jaskelioff et al., 2011).”
T Cell Replicative Senescence in Human Aging
P. Chou, J., & B. Effros, R. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805219711 · Cited by 323
“However, when the inactivated telomerase was switched back on by feeding the mice a chemical called 4-OHT, there was a dramatic reversal of the age-related phenotype: the animals regained their fertility, and other organs such as the brain, spleen, liver and intestines showed correction of their degenerated state [78].”
BackgroundNeedham, B. L., Adler, N., Gregorich, S., Rehkopf, D., Lin, J., Blackburn, E. H., & Epel, E. S. (2013) · Social Science & Medicine · doi:10.1016/j.socscimed.2013.02.023 · Cited by 321
“New experimental models in mice have shown that insufficient telomerase promotes accelerated aging and mortality, whereas high telomerase reverses aging deficits (Bernardes de Jesus et al., 2012; Jaskelioff et al., 2011).”
BackgroundMechanisms that Regulate Stem Cell Aging and Life Span
Signer, R. A. J., & Morrison, S. J. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.001 · Cited by 320
“In addition to protecting against genomic instability, p53 activation following telomere dysfunction also impairs mitochondrial biogenesis, mitochondrial activity, andmetabolic function (Sahin et al., 2011).”
Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer
Hu, J., Hwang, S. S., Liesa, M., Gan, B., Sahin, E., Jaskelioff, M., Ding, Z., Ying, H., Boutin, A. T., Zhang, H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.028 · Cited by 296
“Laser scanning cytometry quantification was performed with an iCys Research Imaging Cytometer (Compucyte) as described earlier (Jaskelioff et al., 2011; Sahin et al., 2011).”
InfluentialSelf-citationEffects of aging on angiogenesis
Lähteenvuo, J., & Rosenzweig, A. (2012) · Circulation Research · doi:10.1161/circresaha.111.246116 · Cited by 292
Loss of Dickkopf-1 Restores Neurogenesis in Old Age and Counteracts Cognitive Decline
Seib, D. R. M., Corsini, N. S., Ellwanger, K., Plaas, C., Mateos, A., Pitzer, C., Niehrs, C., Celikel, T., & Martin-Villalba, A. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.11.010 · Cited by 293
Molecular mechanisms of aging and anti-aging strategies
Li, Y., Tian, X., Luo, J., Bao, T., Wang, S., & Wu, X. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01663-1 · Cited by 293
“Moreover, it has been demonstrated that the anti-aging blood transmissible factors in the blood of young mice can effectively restore the renewal and repair ability of old mice, and reduce the expression of age-related genes [224].”
BackgroundLindqvist, D., Epel, E. S., Mellon, S. H., Penninx, B. W., Révész, D., Verhoeven, J. E., Reus, V. I., Lin, J., Mahan, L., Hough, C. M., et al. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.007 · Cited by 285
Tissue Engineering and Regenerative Medicine: Recent Innovations and the Transition to Translation
Fisher, M. B., & Mauck, R. L. (2013) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2012.0723 · Cited by 263
“In a recent study by Jaskelioff et al.(49) (which also emerged from our objective analysis), the authors investigated how stem cell depletion is related to genome damage.”
Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial
Kiecolt-Glaser, J. K., Epel, E. S., Belury, M. A., Andridge, R., Lin, J., Glaser, R., Malarkey, W. B., Hwang, B. S., & Blackburn, E. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.09.004 · Cited by 259
“Recent work has demonstrated the causal effect of telomerase deficiency and telomere shortening on cellular health and premature aging and mortality in rodents (Bernardes de Jesus et al., 2012; Jaskelioff et al., 2011; Sahin et al., 2011).”
Emerging models and paradigms for stem cell ageing
Jones, D. L., & Rando, T. A. (2011) · Nature Cell Biology · doi:10.1038/ncb0511-506 · Cited by 256
Telomerase at the intersection of cancer and aging
Bernardes de Jesus, B., & Blasco, M. A. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.06.007 · Cited by 227
Aging Hallmarks: The Benefits of Physical Exercise
Rebelo-Marques, A., De Sousa Lages, A., Andrade, R., Ribeiro, C. F., Mota-Pinto, A., Carrilho, F., & Espregueira-Mendes, J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00258 · Cited by 246
“Interestingly, recent evidence supports that telomerase activation can revert aging, namely, in the premature aging of telomerase-deficient mice when the enzyme is genetically reactivated (58).”
BackgroundMaternal psychosocial stress during pregnancy is associated with newborn leukocyte telomere length
Entringer, S., Epel, E. S., Lin, J., Buss, C., Shahbaba, B., Blackburn, E. H., Simhan, H. N., & Wadhwa, P. D. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.11.033 · Cited by 248
“in regeneration of cells and tissues, physiological function, and aging.(6-8)”
Reconsidering the Role of Mitochondria in Aging
Gonzalez-Freire, M., de Cabo, R., Bernier, M., Sollott, S. J., Fabbri, E., Navas, P., & Ferrucci, L. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv070 · Cited by 244
“The importance of PGC-1α to aging is also underlined by recent evidence of an interaction with tumor suppressor p53 and telomerase (42,43).”
BackgroundMoffitt, T. E., & Tank, T. K.-G. 2. T. (2013) · Development and Psychopathology · doi:10.1017/s0954579413000801 · Cited by 236
“With respect to telomere erosion, evidence from a genetically modified mouse model showed that pharmacological activation of telomerase reversed indicators of mouse aging (Jaskelioff et al., 2011).”
BackgroundMolecular mechanism of endothelial and vascular aging: implications for cardiovascular disease
Camici, G. G., Savarese, G., Akhmedov, A., & Lüscher, T. F. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv587 · Cited by 223
“Telomerasedeficient mice are susceptible to progressive tissue atrophy, stem cell depletion, organ system failure, and impaired tissue injury responses, which are reversed by telomerase reactivation.(27) This suggests that telomere shortening is the main determinant of cellular aging.”
BackgroundReactivation of telomerase in cancer
Akincilar, S. C., Unal, B., & Tergaonkar, V. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2146-9 · Cited by 222
“In particular, DNA damage, increased cellular senescence and organ degeneration are key features of aging phenomena due to telomere shortening [26–28].”
BackgroundChanges in Regenerative Capacity through Lifespan
Yun, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025392 · Cited by 216
“Indeed, recent studies show that telomerase reactivation can reverse tissue degeneration in mice with shortened telomeres [97], and improve wound healing as well as”
BackgroundSecreted microvesicular miR-31 inhibits osteogenic differentiation of mesenchymal stem cells
Weilner, S., Schraml, E., Wieser, M., Messner, P., Schneider, K., Wassermann, K., Micutkova, L., Fortschegger, K., Maier, A. B., Westendorp, R., et al. (2016) · Aging Cell · doi:10.1111/acel.12484 · Cited by 212
Ahmed, A. S. I., Sheng, M. H., Wasnik, S., Baylink, D. J., & Lau, K.-H. W. (2017) · World Journal of Experimental Medicine · doi:10.5493/wjem.v7.i1.1 · Cited by 201
Telomeres and Telomerase in Cardiovascular Diseases
Yeh, J.-K., & Wang, C.-Y. (2016) · Genes · doi:10.3390/genes7090058 · Cited by 200
“Experimental studies have reported that the manipulation of telomerase activity and TL enhances or reverses senescence and aging-associated phenotypes [24,116,117].”
BackgroundShort telomere length, myocardial infarction, ischemic heart disease, and early death
Weischer, M., Bojesen, S. E., Cawthon, R. M., Freiberg, J. J., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.237271 · Cited by 197
“Heavy alcohol intake 990 (41) 909 (37) 919 (38) 876 (36) 9 10 5 426 (17) 469 (19) 445 (18) 453 (18) 0.”
The role of telomeres in the mechanisms and evolution of life-history trade-offs and ageing
Young, A. J. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0452 · Cited by 189
Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation
Deschênes-Simard, X., Gaumont-Leclerc, M.-F., Bourdeau, V., Lessard, F., Moiseeva, O., Forest, V., Igelmann, S., Mallette, F. A., Saba-El-Leil, M. K., Meloche, S., et al. (2013) · Genes & Development · doi:10.1101/gad.203984.112 · Cited by 194
The fetal programming of telomere biology hypothesis: an update
Entringer, S., de Punder, K., Buss, C., & Wadhwa, P. D. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2017.0151 · Cited by 191
Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms
Chen, S., Gan, D., Lin, S., Zhong, Y., Chen, M., Zou, X., Shao, Z., & Xiao, G. (2022) · Theranostics · doi:10.7150/thno.71360 · Cited by 190
Assessing cell and organ senescence biomarkers
de Jesus, B. B., & Blasco, M. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.247866 · Cited by 187
Oxidative guanine base damage regulates human telomerase activity
Fouquerel, E., Lormand, J., Bose, A., Lee, H.-T., Kim, G. S., Li, J., Sobol, R. W., Freudenthal, B. D., Myong, S., & Opresko, P. L. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3319 · Cited by 182
Molecular and cellular pathways contributing to brain aging
Zia, A., Pourbagher-Shahri, A. M., Farkhondeh, T., & Samarghandian, S. (2021) · Behavioral and Brain Functions · doi:10.1186/s12993-021-00179-9 · Cited by 181
A genome-wide CRISPR-based screen identifies KAT7 as a driver of cellular senescence
Wang, W., Zheng, Y., Sun, S., Li, W., Song, M., Ji, Q., Wu, Z., Liu, Z., Fan, Y., Liu, F., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd2655 · Cited by 178
Genomic integrity and the ageing brain
Chow, H.-M., & Herrup, K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4020 · Cited by 174
Telomere length loss due to smoking and metabolic traits
Huzen, J., Wong, L. S. M., van Veldhuisen, D. J., Samani, N. J., Zwinderman, A. H., Codd, V., Cawthon, R. M., Benus, G. F. J. D., van der Horst, I. C. C., Navis, G., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12149 · Cited by 174
Vera, E., Bosco, N., & Studer, L. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.062 · Cited by 172
Mice with hyper-long telomeres show less metabolic aging and longer lifespans
Muñoz-Lorente, M. A., Cano-Martin, A. C., & Blasco, M. A. (2019) · Nature Communications · doi:10.1038/s41467-019-12664-x · Cited by 154
Bär, C., de Jesus, B. B., Serrano, R., Tejera, A., Ayuso, E., Jimenez, V., Formentini, I., Bobadilla, M., Mizrahi, J., de Martino, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6863 · Cited by 162
Review: Axon pathology in age‐related neurodegenerative disorders
Adalbert, R., & Coleman, M. P. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01308.x · Cited by 165
Targeted Cargo Delivery in Senescent Cells Using Capped Mesoporous Silica Nanoparticles
Agostini, A., Mondragón, L., Bernardos, A., Martínez‐Máñez, R., Marcos, M. D., Sancenón, F., Soto, J., Costero, A., Manguan‐García, C., Perona, R., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201204663 · Cited by 166
B cell maintenance and function in aging
Kogut, I., Scholz, J. L., Cancro, M. P., & Cambier, J. C. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.04.004 · Cited by 166
Puterman, E., Gemmill, A., Karasek, D., Weir, D., Adler, N. E., Prather, A. A., & Epel, E. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525602113 · Cited by 165
Smith, J. A., Park, S., Krause, J. S., & Banik, N. L. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.02.013 · Cited by 165
“est in telomerase as a therapeutic target for neurodegeneration (Jaskelioff et al., 2011).”
InfluentialAging of mesenchymal stem cell: machinery, markers, and strategies of fighting
Al-Azab, M., Safi, M., Idiiatullina, E., Al-Shaebi, F., & Zaky, M. Y. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00366-0 · Cited by 164
“Taken together, whereas telomerase stimulation can decelerate aging in experimental animals [25, 75], telomere attrition can occur physiologically, but pathologically, these attritions may accelerate aging in mammals and MSCs.”
BackgroundKarnewar, S., Neeli, P. K., Panuganti, D., Kotagiri, S., Mallappa, S., Jain, N., Jerald, M. K., & Kotamraju, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.018 · Cited by 161
Signaling networks determining life span
Riera, C. E., Merkwirth, C., De Magalhaes Filho, C. D., & Dillin, A. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014451 · Cited by 161
“checkpoint responses, eliminates degenerative phenotypes across multiples organs, and reverses neurodegeneration (129).”
BackgroundTelomere-associated aging disorders
Opresko, P. L., & Shay, J. W. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.009 · Cited by 159
Telomere shortening in neurological disorders: an abundance of unanswered questions
Eitan, E., Hutchison, E. R., & Mattson, M. P. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.02.010 · Cited by 158
Rossiello, F., Herbig, U., Longhese, M. P., Fumagalli, M., & di Fagagna, F. D. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.06.009 · Cited by 180
Gametogenesis Eliminates Age-Induced Cellular Damage and Resets Life Span in Yeast
Kinde, B., Ünal, E., & Amon, A. (2011) · DSpace@MIT (Massachusetts Institute of Technology) · Cited by 155
Pont, A. R., Sadri, N., Hsiao, S. J., Smith, S., & Schneider, R. J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.019 · Cited by 139
“Failure to maintain telomere integrity results in genomic instability; DNA damage responses, particularly at the ends of chromosomes; increased cellular senescence; and organ degeneration, which are key drivers of the natural aging process (De Lange, 2005; Jaskelioff et al., 2011; Sahin and Depinho, 2010).”
Liver Regeneration and Aging: A Current Perspective
Schmucker, D. L., & Sanchez, H. C. (2011) · Current Gerontology and Geriatrics Research · doi:10.1155/2011/526379 · Cited by 161
Lee, S. W., Clemenson, G. D., & Gage, F. H. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.10.009 · Cited by 184
“The impact of telomerase activity on NSCs was observed in vitro, where neurospheres isolated from the SVZ of telomerasedeficient adult mice were significantly smaller compared to those from wildtype mice [24] [25] [26].”
BackgroundBlackburn, E. H., & Epel, E. S. (2012) · Nature · doi:10.1038/490169a · Cited by 155
Puterman, E., Lin, J., Krauss, J., Blackburn, E. H., & Epel, E. S. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.70 · Cited by 150
“19,20,78 There are suggestions of quite similar mechanistic bene fi ts of sleep 43,79,80 and nutrition 42,81 on stress-responsive systems.”
Telomeres and Mitochondria in the Aging Heart
Moslehi, J. J., DePinho, R. A., & Sahin, E. (2012) · Circulation Research · doi:10.1161/circresaha.111.246868 · Cited by 169
Self-citationEarly life stress and telomere length: Investigating the connection and possible mechanisms
Shalev, I. (2012) · BioEssays · doi:10.1002/bies.201200084 · Cited by 171
“aged, telomerase-deficient mice through telomerase activation [18].”
BackgroundInventory of telomerase components in human cells reveals multiple subpopulations of hTR and hTERT
Xi, L., & Cech, T. R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku560 · Cited by 160
“In mammals, the activity of telomerase is required by stem cells and the germline, and loss of telomerase activity in these cells results in decreased proliferative capacity (2,3).”
Cellular Senescence as the Causal Nexus of Aging
Bhatia‐Dey, N., Kanherkar, R. R., Stair, S. E., Makarev, E., & Csoka, A. B. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00013 · Cited by 152
“…in vivo in late generations of genetically engineered telomerase-deficient transgenic mouse strains (TERTER) resulted in the extension of typically short telomeres and reversed neurodegeneration and other degenerative features in the spleen, intestine, and testes (Jaskelioff et al., 2011).”
BackgroundDAMPs, ageing, and cancer: The ‘DAMP Hypothesis’
Huang, J., Xie, Y., Sun, X., Zeh, H. J., Kang, R., Lotze, M. T., & Tang, D. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.10.004 · Cited by 144
Dissecting Aging and Senescence—Current Concepts and Open Lessons
Schmeer, C. W., Kretz, A., Wengerodt, D., Stojiljkovic, M. R., & Witte, O. W. (2019) · Cells · doi:10.3390/cells8111446 · Cited by 170
“Overexpression of telomerase has been shown to reverse several aging phenotypes in multiple tissues including the CNS and to increase lifespan [171].”
BackgroundKohama, S. G., Rosene, D. L., & Sherman, L. S. (2011) · AGE · doi:10.1007/s11357-011-9357-7 · Cited by 153
“A striking recent study by Jaskelioff et al. (2011) utilized a transgenic mouse model in which mice with shortened dysfunctional telomeres can be induced to reactivate telomeres, resulting in reduced DNA damage signaling.”
BackgroundTherapeutic Targeting of Telomerase
Jäger, K., & Walter, M. (2016) · Genes · doi:10.3390/genes7070039 · Cited by 157
“These pathways are functionally-relevant downstream drug effects and are also activation pathways for telomerase, suggesting a potential (yet unproven) mechanism by which these drugs may mediate neurogenesis via telomerae activation [38,128].”
BackgroundLozano-Torres, B., Estepa-Fernández, A., Rovira, M., Orzáez, M., Serrano, M., Martínez-Máñez, R., & Sancenón, F. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0108-0 · Cited by 140
Aguado, J., Sola-Carvajal, A., Cancila, V., Revêchon, G., Ong, P. F., Jones-Weinert, C. W., Wallén Arzt, E., Lattanzi, G., Dreesen, O., Tripodo, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13018-3 · Cited by 133
Telomerase Is Required for Zebrafish Lifespan
Henriques, C. M., Carneiro, M. C., Tenente, I. M., Jacinto, A., & Ferreira, M. G. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003214 · Cited by 133
Epigenetic regulation of aging stem cells
Pollina, E. A., & Brunet, A. (2011) · Oncogene · doi:10.1038/onc.2011.45 · Cited by 111
“Recent evidence suggests that inducible reactivation of the enzyme telomerase is sufficient to restore both the proliferation and neuronal differentiation of NSCs in the adult brain and improve defects in olfactory dysfunction, which is linked with NSC decline, in lategeneration telomerase-deficient mice (Jaskelioff e…”
BackgroundMechanisms of Hippocampal Aging and the Potential for Rejuvenation
Fan, X., Wheatley, E., & Villeda, S. (2017) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-072116-031357 · Cited by 139
Metadata
- Authors
- Jaskelioff, M., Muller, F. L., Paik, J.-H., Thomas, E., Jiang, S., Adams, A. C., Sahin, E., Kost-Alimova, M., Protopopov, A., Cadiñanos, J., Horner, J. W., Maratos-Flier, E., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- DePinho, Ronald A.
- ORCID
- Venue
- Nature
- Published
- 2010-11-28
- Volume
- 469
- Issue
- 7328
- Pages
- 102-106
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3057569
- OpenAlex
- W2053352181
- Semantic Scholar
- e8979f16fd203e2da6b0b4ab00099b85b2df9b18
- Cited by
- 857
- References
- 36
- Citations by year
- 2026: 33 · 2025: 42 · 2024: 43 · 2023: 45 · 2022: 43 · 2021: 80 · 2020: 45 · 2019: 54 · 2018: 45 · 2017: 60 · 2016: 55 · 2015: 49 · 2014: 62 · 2013: 70 · 2012: 67
- FWCI
- 43.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (U01CA141508, R01CA084628)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- telomerase reactivation, telomere elongation, telomere dysfunction, aging, tissue degeneration, DNA damage signaling, regenerative therapy, stem cell depletion, cellular senescence, carcinogenesis risk
- MeSH terms
- Doublecortin Protein, Aging, Animals, Avoidance Learning, Brain, Cell Differentiation, Cells, Cultured, DNA Damage, Enzyme Activation, Enzyme Reactivators, Mice, Inbred C57BL, Myelin Sheath, Organ Size, Phenotype, Receptors, Estrogen, Recombinant Fusion Proteins, Smell, Tamoxifen, Telomere, Telomerase, Models, Animal, Regenerative Medicine, Cell Proliferation, Mice, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.